Log in or Sign up
to access My Account functionalities
DIRECT HEALTHCARE PROFESSIONAL COMMUNICATION - Tibsovo▼ 250 mg filmcoated tablets: Interim Supply of Irish packs to Mitigate Supply Disruption
Servier Laboratories Limited is currently experiencing supply disruption with TIBSOVO▼ (ivosidenib) in Great Britain. To ensure supply, Servier Laboratories Ltd has obtained approval from the MHRA to supply Irish packs (batch number W072782B, expiry date 09/2026) which is expected to be on the GB market from July 2023.